SHELL ASSET MANAGEMENT CO - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 3 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$390
-9.9%
14,147
-1.7%
0.02%
-5.9%
Q2 2023$433
-17.4%
14,391
-0.6%
0.02%
-22.7%
Q1 2023$524
+1.2%
14,472
-0.3%
0.02%
-4.3%
Q4 2022$518
-99.9%
14,522
-17.6%
0.02%0.0%
Q3 2022$597,000
-7.2%
17,626
-20.7%
0.02%
+21.1%
Q2 2022$643,000
-10.3%
22,232
+0.2%
0.02%
+11.8%
Q1 2022$717,000
-3.5%
22,187
-12.9%
0.02%
+13.3%
Q4 2021$743,000
+9.9%
25,468
+0.4%
0.02%0.0%
Q3 2021$676,000
-17.0%
25,360
-4.1%
0.02%
-6.2%
Q2 2021$814,000
+24.3%
26,450
+5.7%
0.02%
+23.1%
Q1 2021$655,000
+28.7%
25,020
+23.6%
0.01%
+18.2%
Q4 2020$509,000
+20.6%
20,2470.0%0.01%
+10.0%
Q3 2020$422,000
+17.5%
20,247
+34.1%
0.01%
+11.1%
Q2 2020$359,000
-64.3%
15,099
-50.4%
0.01%
-59.1%
Q2 2019$1,007,000
-7.7%
30,436
-2.2%
0.02%
-8.3%
Q1 2019$1,091,000
+5.5%
31,1270.0%0.02%
-7.7%
Q4 2018$1,034,000
-39.1%
31,127
-7.7%
0.03%
-23.5%
Q3 2018$1,698,000
-39.9%
33,727
-28.5%
0.03%
-41.4%
Q2 2018$2,824,000
+23.9%
47,192
-5.2%
0.06%
+28.9%
Q1 2018$2,279,000
+14.9%
49,7590.0%0.04%
+15.4%
Q4 2017$1,983,000
-0.4%
49,7590.0%0.04%
-11.4%
Q3 2017$1,990,000
-9.2%
49,759
-2.2%
0.04%
-6.4%
Q2 2017$2,192,000
+37.7%
50,8590.0%0.05%
+34.3%
Q1 2017$1,592,000
+15.9%
50,859
-6.5%
0.04%
+9.4%
Q4 2016$1,374,000
+1.2%
54,418
-0.9%
0.03%
+14.3%
Q3 2016$1,358,000
+16.2%
54,893
-4.4%
0.03%
+3.7%
Q2 2016$1,169,00057,4110.03%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 699,432$35,216,0004.25%
Provident Investment Management, Inc. 590,269$29,720,0004.23%
CAPITAL MANAGEMENT CORP /VA 225,232$11,340,0002.90%
FALCON POINT CAPITAL, LLC 188,341$9,483,0002.04%
Ranger Investment Management 600,464$30,233,0002.00%
NEUMEIER POMA INVESTMENT COUNSEL LLC 471,260$23,728,0001.96%
KOPP INVESTMENT ADVISORS LLC 41,700$2,100,0001.77%
SHAKER INVESTMENTS LLC/OH 49,617$2,498,0001.54%
Bruce & Co., Inc. 148,058$7,454,0001.44%
Bridge City Capital, LLC 45,843$2,308,0001.43%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders